Evidence map›Paper›PMID 38233516›Full record

ArticleScientific reports2024

NeuroNet19: an explainable deep neural network model for the classification of brain tumors using magnetic resonance imaging data.

Rezuana Haque, Md Mehedi Hassan, Anupam Kumar Bairagi, Sheikh Mohammed Shariful Islam

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rezuana Haque *Computer Science and Engineering, BGC Trust University Bangladesh, Chittagong, Bangladesh.
Md Mehedi Hassan *Computer Science and Engineering Discipline, Khulna University, Khulna, 9208, Bangladesh. mehedihassan@ieee.org.
Anupam Kumar BairagiComputer Science and Engineering Discipline, Khulna University, Khulna, 9208, Bangladesh.
Sheikh Mohammed Shariful IslamInstitute for Physical Activity and Nutrition, Deakin University, Melbourne, VIC 3125, Australia. shariful.islam@deakin.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors (BTs) are one of the deadliest diseases that can significantly shorten a person's life. In recent years, deep learning has become increasingly popular for detecting and classifying BTs. In this paper, we propose a deep neural network architecture called NeuroNet19. It utilizes VGG19 as its backbone and incorporates a novel module named the Inverted Pyramid Pooling Module (iPPM). The iPPM captures multi-scale feature maps, ensuring the extraction of both local and global image contexts. This enhances the feature maps produced by the backbone, regardless of the spatial positioning or size of the tumors. To ensure the model's transparency and accountability, we employ Explainable AI. Specifically, we use Local Interpretable Model-Agnostic Explanations (LIME), which highlights the features or areas focused on while predicting individual images. NeuroNet19 is trained on four classes of BTs: glioma, meningioma, no tumor, and pituitary tumors. It is tested on a public dataset containing 7023 images. Our research demonstrates that NeuroNet19 achieves the highest accuracy at 99.3%, with precision, recall, and F1 scores at 99.2% and a Cohen Kappa coefficient (CKC) of 99%.

Indexed as

Brain NeoplasmsGliomaMeningeal NeoplasmsHumansMagnetic Resonance ImagingNeural Networks, Computer

Identifiers

PMID38233516
PMCPMC10794704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.